GovChime
AWARDDELIVERY ORDERSmall business

Delivery order 75F40121F19062MIDNIGHT SUN TECHNOLOGIES LLC

Overview

Award facts

Net obligations
$235.16K
$235,156of $235.16K potential value
Outlays (paid to date)
$235.16K
$235.16K paid of $235.16K obligated$235,156
Period of performance
Jun 8, 2021 to Sep 15, 2023
Ended
Modifications
2
Latest action Jun 30, 2026
Contract type
Delivery order
PIID 75F40121F19062

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

SCIENTIFIC ADMIN SUPPORT SPECIALIST LEVEL II FOR THE FDA CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER), FOR ONGOING RESEARCH IN GENE THERAPY AT THE BYRNES LAB

Dates and value

Award date
Signed on Jun 8, 2021
Current value
$235,156Base and exercised options
Potential value (if all options are exercised)
$235,156
Parent contract vehicle
75F40119D10015 (IDC, single award) — 92 orders recorded under it

Obligations by fiscal year of action

  • FY2026: -$26,664 (de-obligation)
  • FY2022: $132,485
  • FY2021: $129,336

Total across 3 fiscal years: $235,156

Net de-obligation in that fiscal year (obligations withdrawn).

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jun 30, 2026. View on USAspending · Recipient on SAM.gov

Recipient

NameMIDNIGHT SUN TECHNOLOGIES LLC
LocationVIENNA, VA
UEIZKR5F6EZNAD2
CAGE code7DG52
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyKIKIKTAGRUK INUPIAT CORP

Business types and certifications

Minority-ownedSelf-certified small disadvantaged businessSBA 8(a) program participantAlaska Native Corporation ownedFor-profit organizationLimited liability companyCorporation (not tax-exempt)

As represented in SAM.gov at the time of the action.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. Food And Drug Administration
  3. FDA OFFICE OF ACQ GRANT SVCS
Funded by
  1. Department of Health and Human Services
  2. Food And Drug Administration
  3. FDA OFFICE OF ACQ GRANT SVCS
Funded from
BiologicsProgram activities075-0600Federal accounts (agency financial reports)

Place of performance

Place of performance
Silver Spring, Montgomery County, Maryland 20993-0002
Congressional district (place of performance)
MD-08As reported at the time of the action

Classification and competition

Classification

NAICS
541690OTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES
Product or service (PSC)
R499SUPPORT- PROFESSIONAL: OTHER (service)

Competition

Extent competed
Not available for competitionB
Reason not competed
Authorized by statute (FAR 6.302-5(A)(2)(I))OTH
Solicitation procedures
Only one sourceSSS
Set-aside
8(a) sole source8AN
Contract pricing
Labor hoursZ

Contract details

Subcontracting plan
Plan not requiredB
Certified cost or pricing data
Yes
Service Contract Act labor standards
Yes
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Transaction history

Modification history

Base award
Jun 8, 2021Base obligation at award: $129,336
Latest action
Jun 30, 2026 — CloseoutModification P00002; obligation change -$26,664; administrative: no change in scope or value
Latest substantive action
May 27, 2022 — Option exercisedModification P00001; obligation change +$132,485
Actions by type
  • Base award1
  • Option exercised1
  • Closeout1
3 actions recorded, Jun 8, 2021 to Jun 30, 2026; each action counted once.

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$26,664
Latest action: change in base and all options
-$26,664

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Delivery orderC
Parent vehicle type
IDCB
Parent vehicle: multiple or single award
Single awardS
Parent vehicle agency
Food And Drug Administration7524
Awarding agency code
7500
Awarding sub-tier code
7524
Contracting office code
75F401
Transactions recorded under this award key
3

Funding

Funding agency code
7500
Funding sub-tier code
7524
Funding office code
75F401
Treasury accounts
  • 075-2021/2021-0600-000
  • 075-2022/2022-0600-000
Object classes
  • 25.1: Advisory and assistance services
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression